Clinical Trials Logo
  1. Home
  2. Hemoptysis
  3. NCT01171768

The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis

Hemoptysis Clinical Trial

Official title:
The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis

Clinical Trial Summary

Vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) are major mediators of angiogenesis and are induced by tissue inflammation and hypoxia. While elevated serum VEGF levels have been reported in inflammatory lung diseases, especially with hemoptysis, there was no study to evaluate the Ang-2 levels in lung inflammatory diseases according to the presence of hemoptysis, inflammatory biomarker and hypoxia.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01171768
Study type Observational
Source Samsung Medical Center
Contact
Status Completed
Phase N/A
Start date June 2008
Completion date December 2010
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02913365 - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis N/A
Completed NCT00387374 - Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab Phase 2
Completed NCT05513248 - Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019
Recruiting NCT05634200 - Utility of Bronchoscopy in Patients With Haemoptysis and Negative Chest CT Scan
Recruiting NCT05554731 - Development and Application of a New Balloon Catheter for Intraairway Hemostasis N/A
Recruiting NCT06144398 - Single Use Flexible Bronchoscopes in Interventional Pulmonary Procedures N/A
Completed NCT01278199 - Bronchial Artery Embolization and Medical Measures in Non Severe Acute Hemoptysis of Mild-moderate Abundance N/A
Recruiting NCT04961528 - ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial. Phase 3
Recruiting NCT05786781 - An Exploratory Study on the Application of Transarterial CT Angiography in the Interventional Treatment of Hemoptysis N/A
Completed NCT04087135 - Comparison of Intubation With Direct Laryngoscopy or Videolaryngoscopy in an Hemoptysis Simulated Situation on Human Cadaver Embalmed With Thiel's Method N/A
Recruiting NCT03270735 - A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection Phase 4
Completed NCT00929565 - Urokinase Like Plasminogen Activator Levels in Patients Undergoing Bronchoscopy N/A
Withdrawn NCT01167764 - Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis Phase 3
Completed NCT03126968 - Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies Phase 2/Phase 3
Completed NCT02781597 - Efficacy of Tranexamic Acid in Hemoptysis Phase 3
Recruiting NCT05648656 - TXA Nebulization for the Treatment of Hemoptysis Phase 3
Completed NCT04771923 - Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding N/A
Recruiting NCT06145191 - Prophylactic Tranexamic Acid Versus Adrenaline During Flexible Bronchoscopy N/A
Completed NCT04770675 - Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.
Completed NCT06067997 - Prevalence Of Pulmonary Embolism In Patients With HEmoptysis (POPEIHE)